825 related articles for article (PubMed ID: 25257546)
21. Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease.
Kiss LS; Szamosi T; Molnar T; Miheller P; Lakatos L; Vincze A; Palatka K; Barta Z; Gasztonyi B; Salamon A; Horvath G; Tóth GT; Farkas K; Banai J; Tulassay Z; Nagy F; Szenes M; Veres G; Lovasz BD; Vegh Z; Golovics PA; Szathmari M; Papp M; Lakatos PL;
Aliment Pharmacol Ther; 2011 Oct; 34(8):911-22. PubMed ID: 21883326
[TBL] [Abstract][Full Text] [Related]
22. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P
Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
[TBL] [Abstract][Full Text] [Related]
23. Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: A European multicentre observational cohort study.
Tai FWD; Ellul P; Elosua A; Fernandez-Urien I; Tontini GE; Elli L; Eliakim R; Kopylov U; Koo S; Parker C; Panter S; Sidhu R; McAlindon M
United European Gastroenterol J; 2021 Mar; 9(2):248-255. PubMed ID: 32741315
[TBL] [Abstract][Full Text] [Related]
24. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
[TBL] [Abstract][Full Text] [Related]
25. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.
Colombel JF; Reinisch W; Mantzaris GJ; Kornbluth A; Rutgeerts P; Tang KL; Oortwijn A; Bevelander GS; Cornillie FJ; Sandborn WJ
Aliment Pharmacol Ther; 2015 Apr; 41(8):734-46. PubMed ID: 25728587
[TBL] [Abstract][Full Text] [Related]
26. Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study.
Melmed GY; Dubinsky MC; Rubin DT; Fleisher M; Pasha SF; Sakuraba A; Tiongco F; Shafran I; Fernandez-Urien I; Rosa B; Papageorgiou NP; Leighton JA
Gastrointest Endosc; 2018 Dec; 88(6):947-955.e2. PubMed ID: 30086261
[TBL] [Abstract][Full Text] [Related]
27. Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center.
Nobile S; Gionchetti P; Rizzello F; Calabrese C; Campieri M
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):458-65. PubMed ID: 24445727
[TBL] [Abstract][Full Text] [Related]
28. Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases.
Roblin X; Marotte H; Rinaudo M; Del Tedesco E; Moreau A; Phelip JM; Genin C; Peyrin-Biroulet L; Paul S
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):80-84.e2. PubMed ID: 23891927
[TBL] [Abstract][Full Text] [Related]
29. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K
Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
[TBL] [Abstract][Full Text] [Related]
30. Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factors.
Papi C; Fascì-Spurio F; Rogai F; Settesoldi A; Margagnoni G; Annese V
Dig Liver Dis; 2013 Dec; 45(12):978-85. PubMed ID: 24018244
[TBL] [Abstract][Full Text] [Related]
31. Evaluation and comparison of capsule endoscopy scores for assessment of inflammatory activity of small-bowel in Crohn's disease.
Ponte A; Pinho R; Rodrigues A; Silva J; Rodrigues J; Sousa M; Carvalho J
Gastroenterol Hepatol; 2018 Apr; 41(4):245-250. PubMed ID: 29249271
[TBL] [Abstract][Full Text] [Related]
32. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
[TBL] [Abstract][Full Text] [Related]
33. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
[TBL] [Abstract][Full Text] [Related]
34. Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice.
Echarri A; Ollero V; Barreiro-de Acosta M; Fernández-Villaverde A; Hernández V; Lorenzo A; Pereira S; Carpio D; Castro J;
Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):430-5. PubMed ID: 25874517
[TBL] [Abstract][Full Text] [Related]
35. Sequential capsule endoscopy of the small bowel for follow-up of patients with known Crohn's disease.
Niv E; Fishman S; Kachman H; Arnon R; Dotan I
J Crohns Colitis; 2014 Dec; 8(12):1616-23. PubMed ID: 24666976
[TBL] [Abstract][Full Text] [Related]
36. Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn's Disease.
Watanabe K; Matsumoto T; Hisamatsu T; Nakase H; Motoya S; Yoshimura N; Ishida T; Kato S; Nakagawa T; Esaki M; Nagahori M; Matsui T; Naito Y; Kanai T; Suzuki Y; Nojima M; Watanabe M; Hibi T;
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):542-549.e1. PubMed ID: 29104132
[TBL] [Abstract][Full Text] [Related]
37. Small bowel capsule endoscopy and treat-to-target in Crohn's disease: A systematic review.
Le Berre C; Trang-Poisson C; Bourreille A
World J Gastroenterol; 2019 Aug; 25(31):4534-4554. PubMed ID: 31496630
[TBL] [Abstract][Full Text] [Related]
38. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
39. Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
Löwenberg M; Vermeire S; Mostafavi N; Hoentjen F; Franchimont D; Bossuyt P; Hindryckx P; Rispens T; de Vries A; van der Woude CJ; Berends S; Ambarus CA; Mathot R; Clasquin E; Baert F; D'Haens G
Gastroenterology; 2019 Oct; 157(4):997-1006.e6. PubMed ID: 31175865
[TBL] [Abstract][Full Text] [Related]
40. The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease.
Rismo R; Olsen T; Ciu G; Paulssen EJ; Christiansen I; Florholmen J; Goll R
Scand J Gastroenterol; 2012 Oct; 47(10):1200-10. PubMed ID: 22861799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
